DexCom, Inc. (DXCM)
Health Care ยท Surgical & Medical Instruments & Apparatus
DexCom, Inc. (DXCM) is listed on Nasdaq, where its shares have traded since April 14, 2005. SentiSense covers DexCom, Inc. in the Health Care sector, and its Standard Industrial Classification is Surgical & Medical Instruments & Apparatus. Jake Leach is its chief executive officer. The company reports 11,100 employees, and its corporate website is www.dexcom.com.
About DexCom, Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 956 institutions reported holding DXCM, with 380.1 million shares worth $25.6 billion in aggregate. The largest reported holders were Vanguard, BlackRock and State Street. Of the 5 largest reported holders, 4 added shares and 1 reduced its position during the quarter.
More on DXCM
- DXCM sentiment: whether news and social coverage of DexCom, Inc. leans bullish or bearish, and the stories driving it.
- DXCM ownership: all 956 reporting institutions, plus insider and congressional trades.
- DXCM financials: revenue, net income, operating margin and free cash flow by quarter and year.
SentiSense also tracks daily options readings for DexCom, Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does DexCom, Inc. do?
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
What sector is DXCM in?
SentiSense classifies DexCom, Inc. in the Health Care sector, and its Standard Industrial Classification is Surgical & Medical Instruments & Apparatus.
Where does DXCM stock trade?
DexCom, Inc. (DXCM) is listed on Nasdaq, where its shares have traded since April 14, 2005.
Who is the CEO of DexCom, Inc.?
Jake Leach is the chief executive officer of DexCom, Inc..